{"count": 21, "results": [{"_id": "34907484", "pmid": 34907484, "title": "Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma.", "journal": "AAPS PharmSciTech", "authors": ["Sambamoorthy U", "Manjappa AS", "Eswara BRM", "Sanapala AK", "Nagadeepthi N"], "date": "2021-12-14T00:00:00Z", "doi": "10.1208/s12249-021-02177-6", "meta_date_publication": "2021 Dec 14", "meta_volume": "23", "meta_issue": "1", "meta_pages": "23", "score": 50259.97, "text_hl": "Vitamin E Oil Incorporated Liposomal @CHEMICAL_Melphalan @CHEMICAL_MESH:D008558 @@@Melphalan@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable @CHEMICAL_Melphalan @CHEMICAL_MESH:D008558 @@@Melphalan@@@ and Anticancer Activity in Combination with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Against @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@Multiple Myeloma@@@.", "citations": {"NLM": "Sambamoorthy U, Manjappa AS, Eswara BRM, Sanapala AK, Nagadeepthi N. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech. 2021 Dec 14;23(1):23. PMID: 34907484", "BibTeX": "@article{34907484, title={Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma.}, author={Sambamoorthy U and Manjappa AS and Eswara BRM and Sanapala AK and Nagadeepthi N}, journal={AAPS PharmSciTech}, volume={23}, number={1}, pages={23}}"}}, {"_id": "15551657", "pmid": 15551657, "title": "Simvastatin induces death of multiple myeloma cell lines.", "journal": "J Investig Med", "authors": ["Gronich N", "Drucker L", "Shapiro H", "Radnay J", "Yarkoni S", "Lishner M"], "date": "2004-07-01T00:00:00Z", "doi": "10.1136/jim-52-05-34", "meta_date_publication": "2004 Jul", "meta_volume": "52", "meta_issue": "5", "meta_pages": "335-44", "score": 50075.414, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induces death of @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@multiple myeloma@@@ cell lines.", "citations": {"NLM": "Gronich N, Drucker L, Shapiro H, Radnay J, Yarkoni S, Lishner M. Simvastatin induces death of multiple myeloma cell lines. J Investig Med. 2004 Jul;52(5):335-44. PMID: 15551657", "BibTeX": "@article{15551657, title={Simvastatin induces death of multiple myeloma cell lines.}, author={Gronich N and Drucker L and Shapiro H and Radnay J and Yarkoni S and Lishner M}, journal={J Investig Med}, volume={52}, number={5}, pages={335-44}}"}}, {"_id": "15287916", "pmid": 15287916, "title": "Microenvironment factors do not afford myeloma cell lines protection from simvastatin.", "journal": "Eur J Haematol", "authors": ["Osadchy A", "Drucker L", "Radnay J", "Shapira H", "Lishner M"], "date": "2004-09-01T00:00:00Z", "doi": "10.1111/j.1600-0609.2004.00284.x", "meta_date_publication": "2004 Sep", "meta_volume": "73", "meta_issue": "3", "meta_pages": "183-90", "score": 50072.8, "text_hl": "Microenvironment factors do not afford @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@myeloma@@@ cell lines protection from @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Osadchy A, Drucker L, Radnay J, Shapira H, Lishner M. Microenvironment factors do not afford myeloma cell lines protection from simvastatin. Eur J Haematol. 2004 Sep;73(3):183-90. PMID: 15287916", "BibTeX": "@article{15287916, title={Microenvironment factors do not afford myeloma cell lines protection from simvastatin.}, author={Osadchy A and Drucker L and Radnay J and Shapira H and Lishner M}, journal={Eur J Haematol}, volume={73}, number={3}, pages={183-90}}"}}, {"_id": "26426180", "pmid": 26426180, "title": "Simvastatin Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of Multiple Myeloma.", "journal": "West Indian Med J", "authors": ["Jitumori R", "Fernandes D", "Jitumori C", "Favero GM"], "date": "2015-06-01T00:00:00Z", "doi": "10.7727/wimj.2014.227", "meta_date_publication": "2015 Jun", "meta_volume": "64", "meta_issue": "3", "meta_pages": "263-5", "score": 50070.363, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@Multiple Myeloma@@@.", "citations": {"NLM": "Jitumori R, Fernandes D, Jitumori C, Favero GM. Simvastatin Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of Multiple Myeloma. West Indian Med J. 2015 Jun;64(3):263-5. PMID: 26426180", "BibTeX": "@article{26426180, title={Simvastatin Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of Multiple Myeloma.}, author={Jitumori R and Fernandes D and Jitumori C and Favero GM}, journal={West Indian Med J}, volume={64}, number={3}, pages={263-5}}"}}, {"_id": "16917207", "pmid": 16917207, "title": "Synergistic antimyeloma effects of zoledronate and simvastatin.", "journal": "Anticancer Drugs", "authors": ["Schmidmaier R", "Simsek M", "Baumann P", "Emmerich B", "Meinhardt G"], "date": "2006-07-01T00:00:00Z", "doi": "10.1097/01.cad.0000215058.85813.02", "meta_date_publication": "2006 Jul", "meta_volume": "17", "meta_issue": "6", "meta_pages": "621-9", "score": 50068.727, "text_hl": "@CHEMICAL_Zoledronic_Acid @CHEMICAL_MESH:D000077211 @@@Zoledronate@@@ did not show substantial antimyeloma activity at low and intermediate concentrations, whereas @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ potently induced apoptosis in @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@myeloma@@@ cells without signs of primary, cell-adhesion-mediated drug resistance. ", "citations": {"NLM": "Schmidmaier R, Simsek M, Baumann P, Emmerich B, Meinhardt G. Synergistic antimyeloma effects of zoledronate and simvastatin. Anticancer Drugs. 2006 Jul;17(6):621-9. PMID: 16917207", "BibTeX": "@article{16917207, title={Synergistic antimyeloma effects of zoledronate and simvastatin.}, author={Schmidmaier R and Simsek M and Baumann P and Emmerich B and Meinhardt G}, journal={Anticancer Drugs}, volume={17}, number={6}, pages={621-9}}"}}, {"_id": "17655704", "pmid": 17655704, "title": "First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma.", "journal": "Eur J Haematol", "authors": ["Schmidmaier R", "Baumann P", "Bumeder I", "Meinhardt G", "Straka C", "Emmerich B"], "date": "2007-09-01T00:00:00Z", "doi": "10.1111/j.1600-0609.2007.00902.x", "meta_date_publication": "2007 Sep", "meta_volume": "79", "meta_issue": "3", "meta_pages": "240-3", "score": 50068.664, "text_hl": "First clinical experience with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to overcome drug resistance in refractory @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@multiple myeloma@@@.", "citations": {"NLM": "Schmidmaier R, Baumann P, Bumeder I, Meinhardt G, Straka C, Emmerich B. First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma. Eur J Haematol. 2007 Sep;79(3):240-3. PMID: 17655704", "BibTeX": "@article{17655704, title={First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma.}, author={Schmidmaier R and Baumann P and Bumeder I and Meinhardt G and Straka C and Emmerich B}, journal={Eur J Haematol}, volume={79}, number={3}, pages={240-3}}"}}, {"_id": "18055977", "pmid": 18055977, "title": "High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma.", "journal": "Haematologica", "authors": ["van der Spek E", "Bloem AC", "Sinnige HA", "Lokhorst HM"], "date": "2007-12-01T00:00:00Z", "doi": "10.3324/haematol.12071", "meta_date_publication": "2007 Dec", "meta_volume": "92", "meta_issue": "12", "meta_pages": "e130-1", "score": 50068.176, "text_hl": "High dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@myeloma@@@.", "citations": {"NLM": "van der Spek E, Bloem AC, Sinnige HA, Lokhorst HM. High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma. Haematologica. 2007 Dec;92(12):e130-1. PMID: 18055977", "BibTeX": "@article{18055977, title={High dose simvastatin does not reverse resistance to vincristine, adriamycin, and dexamethasone (VAD) in myeloma.}, author={van der Spek E and Bloem AC and Sinnige HA and Lokhorst HM}, journal={Haematologica}, volume={92}, number={12}, pages={e130-1}}"}}, {"_id": "15090747", "pmid": 15090747, "title": "Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines.", "journal": "Anticancer Drugs", "authors": ["Drucker L", "Afensiev F", "Radnay J", "Shapira H", "Lishner M"], "date": "2004-01-01T00:00:00Z", "doi": "10.1097/00001813-200401000-00012", "meta_date_publication": "2004 Jan", "meta_volume": "15", "meta_issue": "1", "meta_pages": "79-84", "score": 50066.25, "text_hl": "Co-administration of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @DISEASE_Drug_Fever @DISEASE_MESH:D000092582 @@@cytotoxic drugs@@@ is advantageous in @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@myeloma@@@ cell lines.", "citations": {"NLM": "Drucker L, Afensiev F, Radnay J, Shapira H, Lishner M. Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines. Anticancer Drugs. 2004 Jan;15(1):79-84. PMID: 15090747", "BibTeX": "@article{15090747, title={Co-administration of simvastatin and cytotoxic drugs is advantageous in myeloma cell lines.}, author={Drucker L and Afensiev F and Radnay J and Shapira H and Lishner M}, journal={Anticancer Drugs}, volume={15}, number={1}, pages={79-84}}"}}, {"_id": "26514497", "pmid": 26514497, "title": "Induction of P3NS1 Myeloma Cell Death and Cell Cycle Arrest by Simvastatin and/or gamma-Radiation.", "journal": "Asian Pac J Cancer Prev", "authors": ["Abdelrahman IY", "Helwa R", "Elkashef H", "Hassan NH"], "date": "2015-01-01T00:00:00Z", "doi": "10.7314/apjcp.2015.16.16.7103", "meta_date_publication": "2015", "meta_volume": "16", "meta_issue": "16", "meta_pages": "7103-10", "score": 50065.72, "text_hl": "Induction of P3NS1 @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@Myeloma@@@ Cell Death and Cell Cycle Arrest by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and/or gamma-Radiation.", "citations": {"NLM": "Abdelrahman IY, Helwa R, Elkashef H, Hassan NH. Induction of P3NS1 Myeloma Cell Death and Cell Cycle Arrest by Simvastatin and/or gamma-Radiation. Asian Pac J Cancer Prev. 2015;16(16):7103-10. PMID: 26514497", "BibTeX": "@article{26514497, title={Induction of P3NS1 Myeloma Cell Death and Cell Cycle Arrest by Simvastatin and/or gamma-Radiation.}, author={Abdelrahman IY and Helwa R and Elkashef H and Hassan NH}, journal={Asian Pac J Cancer Prev}, volume={16}, number={16}, pages={7103-10}}"}}, {"_id": "15069546", "pmid": 15069546, "title": "Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.", "journal": "Oncol Rep", "authors": ["Otsuki T", "Sakaguchi H", "Hatayama T", "Fujii T", "Tsujioka T", "Sugihara T", "Takata A", "Hyodoh F", "Eto M"], "date": "2004-05-01T00:00:00Z", "meta_date_publication": "2004 May", "meta_volume": "11", "meta_issue": "5", "meta_pages": "1053-8", "score": 50064.43, "text_hl": "Effects of an @GENE_HMGCR @GENE_3156 @@@HMG-CoA reductase@@@ inhibitor, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, on @SPECIES_9606 @@@human@@@ @<m>DISEASE_Multiple_Myeloma</m> @DISEASE_MESH:D009101 @@@myeloma@@@ cells.", "citations": {"NLM": "Otsuki T, Sakaguchi H, Hatayama T, Fujii T, Tsujioka T, Sugihara T, Takata A, Hyodoh F, Eto M. Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells. Oncol Rep. 2004 May;11(5):1053-8. PMID: 15069546", "BibTeX": "@article{15069546, title={Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.}, author={Otsuki T and Sakaguchi H and Hatayama T and Fujii T and Tsujioka T and Sugihara T and Takata A and Hyodoh F and Eto M}, journal={Oncol Rep}, volume={11}, number={5}, pages={1053-8}}"}}]}